UBS Group’s Healthcare Services Acquisition Corporation Warrant HCARW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,456
Closed -$1K 11519
2022
Q2
$1K Sell
7,456
-2,500
-25% -$442 ﹤0.01% 10152
2022
Q1
$3K Buy
+9,956
New +$4.27K ﹤0.01% 9566
2021
Q3
Sell
-222
Closed 10448
2021
Q2
$0 Buy
+222
New +$162 ﹤0.01% 10098

Other funds holding HCARW

UBS Group's HCARW Position: Q3 2022 in Review

UBS Group sold out of Healthcare Services Acquisition Corporation Warrant (HCARW) in Q3 2022, closing a stake of 7,456 shares — an estimated $1K sold.

UBS Group first reported a position in HCARW in Q2 2021 and held it in 3 quarters. The position peaked at $3K in Q1 2022. 47 funds tracked by Wall St. Rank hold HCARW as of Q3 2022.

  • UBS Group reported no remaining Healthcare Services Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
  • UBS Group sold 7,456 Healthcare Services Acquisition Corporation Warrant shares in Q3 2022, an estimated $1K.
  • UBS Group first reported a position in Healthcare Services Acquisition Corporation Warrant in Q2 2021 and held it in 3 quarters.
  • UBS Group's Healthcare Services Acquisition Corporation Warrant position peaked at $3K in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Warrant as of Q3 2022.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.